Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The market for lichen sclerosus treatment is characterized by limited therapeutic options, reflecting the challenging nature of this chronic inflammatory skin condition. The scarcity of FDA-approved treatments has spurred ongoing research and development efforts to address the unmet medical needs of individuals affected by lichen sclerosus.
Topical corticosteroids remain the gold standard for treating lichen sclerosus despite newcoming treatments such as Andreol, Cineramen, and Verocin. In addition to anti-inflammatory medications, symptom management is another important focus of care. However, these anti-inflammatory medications may be associated with side effects upon prolonged use and given this notorious problem, the requests for alternative treatments have increased.
Concurrently with hormonal therapies, for instance, estrogen-based treatments in postmenopausal women, scientists are looking at different ways of tackling vulvar lichen sclerosus in postmenopausal women. These treatments are directed at the hormone disturbance responsible for lichen sclerosus, therefore reducing the symptoms and having the potential to be beneficial to the management of disease.
The key factor of the continuation of investigation is the probable functions of biologics and immunomodulators in treatment of lichen sclerosus. These agents attach themselves to particular pathways in the immune system that are when they address the root of the problem, the inflammation involved in the lichen sclerosus rash.
A review of some studies' findings show promising results as regards the use of NSAIDs (nonsteroidal anti-inflammatory drugs) in treating lichen sclerosus. NSAIDs, because of their anti-inflammatory characters, are currently subjected to the research which aims to prove their effectiveness in diminishing inflammation and typical lichen sclerosus symptoms.
Recently there is a transition in the field of treatment programs specific for LS patients. Such shift is towards patient centered approach in LS treatment. The attention is drawn both on physical symptoms itself and also mental health impact of the disease, with patients' overall quality of life improvement being the highlight issue of the disease.
Collaborative research initiatives on a global scale are contributing to advancements in lichen sclerosus treatment. Research collaborations between academic institutions, pharmaceutical companies, and healthcare organizations aim to deepen the understanding of the condition and explore innovative therapeutic approaches.
Patient advocacy and support groups are becoming more prominent in the lichen sclerosus landscape. These groups play a crucial role in raising awareness, providing resources, and fostering a sense of community for individuals affected by lichen sclerosus.
Lichen Sclerosus Treatment Market Highlights:
Market Synopsis of Lichen Sclerosus Treatment Market
The Lichen Sclerosus Treatment market is projected to reach USD 297.9 Million by 2030 at 9.6% CAGR during the forecast period 2022-2030. Lichen sclerosus is a skin disease that affects the genital and anal areas. In some cases, they may appear on upper body such as arms and breast regions. The main cause of lichen sclerosus is still unknown, but some of the other causes are hormonal imbalance, hyper immunity reactions.  Patients with skin destruction around genital or anal region are more susceptible to develop lichen sclerosus. Generally women suffering from vulva’s lichen sclerosus are at a high risk of developing vulvar cancer.
Increasing prevalence of skin diseases worldwide is one of the major factors contributing to the growth of the market. Moreover, hormonal misbalance in females undergoing menopause are more susceptible to lichen sclerosus, which boosts the growth of market.
On the other hand, availability of exact treatment, and unawareness about rare skin diseases among people may hamper the market growth.
FIGURE 1 Lichen Sclerosus Treatment Global Market by mode of administration, 2016 (%) 
Key Players in the Global Lichen Sclerosus Treatment Market Â
Some of the key players in this lichen sclerosus treatment market are AstraZeneca plc, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., Sandoz AG (Novartis AG), Sanofi S.A., Valeant Pharmaceuticals, and Zylera Pharmaceuticals. Â
Lichen Sclerosus Treatment Market Segments                                                               The global sclerosus treatment market is segmented on the basis of type of treatment, which includes drug therapy and surgery. The drug therapy is further segmented into corticosteroid, immune modulating drugs, retinoid like agents, and others. Surgery is further segmented into laser surgery, circumcision, and others.  Â
On the basis of mode of administration, the lichen sclerosus treatment market is segmented into oral, topical, IV (Intravenous), and others. Oral is further segmented into tablets, capsule, and others. The topical administration is further segmented into creams, ointment, and others.Â
On the basis of end user, the lichen sclerosus treatment market is segmented into hospitals, dermatology clinics, pharmacies, and others.
Research Methodology
 
Â
Regional Analysis of the Global Lichen Sclerosus Treatment Market  Â
The American region accounted for the largest share of the global lichen sclerosus treatment market due to increasing prevalence of skin disease and demand for new topical products for its treatment. According to the American Osteopathic College of Dermatology, in 2013, USD 75 billion were spent on skin disease by the Americans. Aging population is another factor responsible for the market growth in the American countries.
Europe is the second largest market that holds a noticeable share of the global lichen sclerosus treatment market owing to an increasing awareness regarding skin diseases, demand for skin care cosmetics, and growing market for dermatology in many European countries.
In Asia Pacific, increasing number of dermatology clinics, rising demand for evidence based skin care, and increasing prevalence of skin diseases drives the growth of the lichen sclerosus treatment market.
The Middle East & Africa is expected to show a steady but positive growth in this market due constant demand for diagnostics services in dermatology.
The report on the global lichen sclerosus treatment market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regionsÂ
Intended Audience
- Medical Device Manufacturers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
